Fundraising Fox
David Sinclair
InvestorVenture Partner at Catalio Capital Management, LP
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to David
35 people in our graph can introduce you to David.
Each arrow is one introduction. Sign up to fill in the first one.
Ask George C. Petrocheilos to introduce you to David
You →George · together at Catalio Capital Management, LP →David
Ask Jamie Chen to introduce you to David
You →Jamie · 11 people · together at Catalio Capital Management, LP →David
Sign up to find every way you can get introduced to David
- Your email: the people you already email who know David
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with David
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
David Sinclair is a Professor of Genetics at Harvard Medical School and Co-Director of the Paul F. Glenn Labs for the Biology of Aging, focusing on longevity and the biology of aging. He holds a BS and PhD from the University of New South Wales and completed a post-doctoral fellowship at MIT. He has co-founded numerous biotechnology companies and authored the New York Times bestseller "Lifespan."
Invests in
BiotechLongevity
Investments
Investor
Arc BioCohBarContinuum BiosciencesGenocea BioscienceIdunaImmetasJumpstart FertilityLiberty BiosecurityLife BiosciencesMetroBiotechRevere BiosensorsSenolytic TherapeuticsSirtris PharmaceuticalsSpotlight Biosciences
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Network4
Investors connected to David in public investor directories — a warm-intro map.
Frequently asked questions
- Who is David Sinclair?
- David Sinclair is a Professor of Genetics at Harvard Medical School and Co-Director of the Paul F. Glenn Labs for the Biology of Aging, focusing on longevity and the biology of aging. He holds a BS and PhD from the University of New South Wales and completed a post-doctoral fellowship at MIT. He has co-founded numerous biotechnology companies and authored the New York Times bestseller "Lifespan."
- Where does David Sinclair work?
- David Sinclair is Venture Partner at Catalio Capital Management, LP.
- What does David Sinclair invest in?
- David Sinclair invests in Biotech, Longevity.
- What check size does David Sinclair write?
- David Sinclair typically writes checks of $100K – $5M.
- What companies has David Sinclair invested in?
- Investments tracked here include Arc Bio, CohBar, Continuum Biosciences, Genocea Bioscience, Iduna, Immetas, Jumpstart Fertility, Liberty Biosecurity, Life Biosciences, MetroBiotech, Revere Biosensors, Senolytic Therapeutics, and 2 more.